Renibus to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference Southlake, Texas, February 5, 2025 – Renibus Therapeutics® (“Renibus”), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardiac, renal, and metabolic diseases, today announced its participation in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference, being held February 11-12, 2025, in a virtual […] The post Renibus to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference appeared first on Renibus Therapeutics .